Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
QuinStreet (NASDAQ:QNST) released fourth-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial data
QUINT, the direct-to-consumer beauty biotechnology brand, has introduced Q.FACE and Q.SCALP—structured monthly microneedling protocols that combine 25 billion exosomes with precision microneedling applicators. The systems are designed to simplify at-home skincare and scalp treatments by offering standardized dosing, guided application, and a three-month protocol, positioning exosomes as an intentional treatment rather than a daily cosmetic ingredient.
QuinStreet CFO Gregory Wong sold 11,704 shares worth approximately $239,230 on August 18, 2026, representing 2% of his direct holdings. Wong retains 481,786 shares valued at $10 million. The article characterizes this as routine profit-taking given the stock's strong 41% performance over the past 12 months and management's positive fiscal 2027 revenue growth projections of 16-31%.
U.S. stocks rose, Nasdaq Composite up 1%. Natera Inc (NTRA) shares jump 20.5% after strong Q2 results and raised FY26 sales guidance. Other big gains include DOCS, QNST, TEAM, CRSR, OABI, PUBM, TWLO, BTG, and ROAD.